Delivery Order SPE2DB20D3101-SPE2DB25FRTF9
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $59,699.64 for XEOMIN 100 Unit Vials under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain on September 3, 2025. The contract requires completion by September 24, 2025, and involves no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of XEOMIN 100 unit vials. This competitive delivery order, valued at $46,375.42, represents a firm fixed-price contract with an ultimate completion date of September 15, 2025. The award was not set-aside and reflects AmerisourceBergen's capability to meet federal pharmaceutical procurement requirements through open competition. The work will be...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,644.72 by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Xeomin 200 unit vials. The contract utilizes firm fixed price terms with an ultimate completion date of June 24, 2025, and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet federal procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,587.40 for 100-unit vials of XEOMIN on June 9, 2025, with completion scheduled for July 1, 2025. This firm fixed-price, non-competitive delivery order was issued through the Defense Logistics Agency's Medical Supply Chain to support federal medical procurement needs. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 100-unit vials of XEOMIN, a pharmaceutical product commonly used in medical treatments. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,793.70 and is scheduled for completion by October 8, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for 100-unit vials of XEOMIN on August 21, 2025. The contract has a ceiling value of $2,514.33 and represents a firm fixed-price delivery order with a completion date of September 12, 2025. This award carries no set-aside designation and was competitively awarded through DLA's procurement process. The place of performance is located...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $59,699.64 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, utilizing firm fixed-price pricing, covers the supply of Xeomin 100 unit vials and is scheduled for completion by August 27, 2025. The award was made through open competition with no set-aside designation, with performance taking place at the vendor's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $13,968.50 under a firm fixed-price contract. The order covers XEOMIN 100 UT vials, a botulinum toxin product used for medical purposes, with delivery required by August 29, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal defense and healthcare systems, with...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on August 23, 2025, for the supply of Xeomin 100 Unit vials. The contract ceiling value is $11,174.80, with an ultimate completion date of September 12, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procurement, consistent with AmerisourceBergen's...